Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice

被引:95
作者
Horuzsko, A
Lenfant, F
Munn, DH
Mellor, AL
机构
[1] Med Coll Georgia, Dept Med, Program Mol Immunol, CA 2006, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA
[3] CHU Purpan, INSERM, U395, F-31024 Toulouse, France
关键词
dendritic cells; HLA-G; mice; T cells;
D O I
10.1093/intimm/13.3.385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human MHC class Ib antigen HLA-G is thought to regulate maternal immune responses during pregnancy. Here we show that expression of HLA-G in transgenic mice diminished cellular immunity by inhibiting maturation of myelomonocytic cells into functional antigen-presenting cells (APC), Skin allografts applied to HLA-G transgenic mice survived longer and resultant T cell responses were less potent compared to control mice, T cells from HLA-G mice responded normally to allogeneic APC and immunohistological analyses of spleen revealed no marked abnormalities. However, spontaneous outgrowths of myeloid cells were observed when bone marrow or splenocytes from HLA-G mice were cultured in vitro, but functionally competent APC did not develop spontaneously in bone marrow cultures supplemented with granulocyte macrophage colony stimulating factor (GM-CSF). Addition of lipopolysaccharide (LPS) to GM-CSF-derived bone marrow cultures rescued APC maturation. Studies using HLA-G tetrameric reagents revealed that HLA-G-specific binding activity was associated with CD11c(+) myelomonocytic cells, while binding to lymphoid and NK cell subsets was undetectable, These data show that spontaneous maturation of functionally competent dendritic cells IDC) is compromised in HLA-G mice. We hypothesize that HLA-G inhibits maturation of DC via receptor-mediated interactions with myelomonocytic precursors, which render immature DC precursors unable to receive signals from activated T cells.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 35 条
  • [1] Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells
    Allan, DSJ
    Colonna, M
    Lanier, LL
    Churakova, TD
    Abrams, JS
    Ellis, SA
    McMichael, AJ
    Braud, VM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) : 1149 - 1155
  • [2] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [3] Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice
    Ando, Y
    Beck, Y
    Tomikawa, S
    Eriguchi, M
    Muto, T
    Takiguchi, M
    [J]. TRANSPLANTATION, 1999, 68 (06) : 904 - 908
  • [4] Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor - Convergence at the cyclin E/p27(Kip1) regulatory checkpoint
    Antonov, AS
    Munn, DH
    Kolodgie, FD
    Virmani, R
    Gerrity, RG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (12) : 2867 - 2876
  • [5] BILLINGHAM RE, 1951, J EXP BIOL, V28, P385
  • [6] HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
    Braud, VM
    Allan, DSJ
    O'Callaghan, CA
    Söderström, K
    D'Andrea, A
    Ogg, GS
    Lazetic, S
    Young, NT
    Bell, JI
    Phillips, JH
    Lanier, LL
    McMichael, AJ
    [J]. NATURE, 1998, 391 (6669) : 795 - 799
  • [7] Origin, maturation and antigen presenting function of dendritic cells
    Cella, M
    Sallusto, F
    Lanzavecchia, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 10 - 16
  • [8] MECHANISMS OF TRANSPLANTATION TOLERANCE
    CHARLTON, B
    AUCHINCLOSS, H
    FATHMAN, CG
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 707 - 734
  • [9] Nonclassical HLA-G molecules are classical peptide presenters
    Diehl, M
    Munz, C
    Keilholz, W
    Stevanovic, S
    Holmes, N
    Loke, YW
    Rammensee, HG
    [J]. CURRENT BIOLOGY, 1996, 6 (03) : 305 - 314
  • [10] Grigoriadou K, 1999, EUR J IMMUNOL, V29, P3683, DOI 10.1002/(SICI)1521-4141(199911)29:11<3683::AID-IMMU3683>3.0.CO